Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;13:456-462

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okamoto, H.
Right arrow Articles by Yasuda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamoto, H.
Right arrow Articles by Yasuda, H.

Hypertension, Vol 13, 456-462, Copyright © 1989 by American Heart Association


ARTICLES

Lipid alterations in renal membrane of stoke-prone spontaneously hypertensive rats

H Okamoto, H Kawaguchi, M Minami, H Saito and H Yasuda
Department of Cardiovascular Medicine and Pharmacology, Hokkaido University School of Medicine, Sapporo, Japan.

Phospholipase A2 activity, phospholipids, and phospholipid fatty acids were investigated in renal membrane of male stroke-prone spontaneously hypertensive rats (SHRSP) and age-matched Wistar-Kyoto rats. Renal phospholipase A2 activity increased and membranous phospholipids especially phosphatidylcholine and phosphatidylethanolamine, decreased with age in SHRSP. Arachidonate in phospholipid also decreased with age in SHRSP. To determine the effect of pressure load on the lipid alterations in renal membrane, SHRSP that received antihypertensive treatment with hydralazine, enalapril, or nicardipine for 5 weeks were compared with those without treatment. Antihypertensive treatments prevented phospholipid degradation and increased arachidonate in phospholipid relative to the control group. Phospholipase A2 activity in each group treated with antihypertensive drugs did not differ from that in the control group. These results suggest that the course of hypertension causes renal membranous phospholipid degradation and increases phospholipase A2 activity. Antihypertensive treatments may prevent these lipid alterations in SHRSP. These renal membranous structural changes may provide an explanation not only for functional abnormalities such as decreased membrane fluidity but also for the progress of hypertension.


This article has been cited by other articles:


Home page
HypertensionHome page
F. Barcelo, J. S. Perona, J. Prades, S. S. Funari, E. Gomez-Gracia, M. Conde, R. Estruch, and V. Ruiz-Gutierrez
Mediterranean-Style Diet Effect on the Structural Properties of the Erythrocyte Cell Membrane of Hypertensive Patients: The Prevencion con Dieta Mediterranea Study
Hypertension, November 1, 2009; 54(5): 1143 - 1150.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. V. Escriba, J. M. Sanchez-Dominguez, R. Alemany, J. S. Perona, and V. Ruiz-Gutierrez
Alteration of Lipids, G Proteins, and PKC in Cell Membranes of Elderly Hypertensives
Hypertension, January 1, 2003; 41(1): 176 - 182.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Ohya, N. Adachi, Y. Nakamura, M. Setoguchi, I. Abe, and M. Fujishima
Stretch-Activated Channels in Arterial Smooth Muscle of Genetic Hypertensive Rats
Hypertension, January 1, 1998; 31(1): 254 - 258.
[Abstract] [Full Text] [PDF]